Bioelectronics Corp 

(Public, OTC:BIEL)   Watch this stock   
Find more results for BIEL

Key stats and ratios

Q2 (Jun '09) 2008
Net profit margin 14.12% -257.74%
Operating margin 14.12% -244.21%
EBITD margin - -
Return on average assets 40.32% -509.79%
Return on average equity - -

Address

4539 Metropolitan Court
Frederick, MD 21704
United States - Map
+1-301-6443906 (Phone)

Website links

Bioelectronics Corp discussed on blogs

Stock Market Analysis: Hot OTC Pink Sheets Stocks November 20 2009 - tweid05@gmail.com (stockstobuy.org) - Stock Market Analysis - 13 hours ago
Stock Market Analysis: Stocks to Buy 11/20/09 November 20, 2009 - tweid05@gmail.com (stockstobuy.org) - Stock Market Analysis - Nov 19, 2009
Stock Market Analysis: Hot OTC Pink Sheets Stocks November 19 2009 - stockstobuy.org - Stock Market Analysis - Nov 19, 2009

Bioelectronics Corp discussions

  View all discussions »

Description

BioElectronics Corporation (BioElectronics) designs, develops and markets a variety of drug-free, anti-inflammatory patches for a range of medical indications. The Company's patch products, which are marketed under the name ActiPatch Therapy, deliver pulsed electromagnetic field therapy, an anti-inflammatory and pain relief therapy. The ActiPatch Therapy products combine a miniaturized microchip, power source and antenna in a soft, flexible outer envelope. When applied to the body, these devices deliver a pulsed radio frequency signal into the body on a 27 megahertz (MHz) frequency wave that induces a low frequency electromagnetic field to damaged cell tissue.

Officers and directors

Andrew J. Whelan
Chairman of the Board, President
Age: 64
Lawrence H. Rosen
Chief Financial Officer, Secretary
Age: 64
Brian M. Kinney M.D.
Director
Age: 50
Ashton Peery
Director
Age: 54
Mary Whelan
Director
Age: 55
Richard Staelin Ph.D.
Director
Age: 66